A longitudinal study of type-specific antibody responses to Plasmodium falciparum merozoite surface protein-1 in an area of unstable malaria in Sudan

Journal of Immunology

Volumn 161, Issue 1, 1998, Pages 347-359

  Cavanagh, David R ^a   Elhassan, Ibrahim M ^b   Roper, Cally ^a   Robinson, V Jane ^a   Giha, Haider ^b   Holder, Anthony A ^d   Hviid, Lars ^c   Theander, Thor G ^c   Arnot, David E ^a   McBride, Jana S ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b UNIVERSITY OF KHARTOUM   (Sudan)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

^d NATIONAL INSTITUTE FOR MEDICAL RESEARCH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CHLOROQUINE; IMMUNOGLOBULIN G; MEMBRANE PROTEIN; MEROZOITE SURFACE PROTEIN 1; PYRIMETHAMINE; SULFADOXINE; UNCLASSIFIED DRUG;

ADULT; AMINO TERMINAL SEQUENCE; ANTIBODY RESPONSE; ANTIGEN RECOGNITION; ANTIGEN SPECIFICITY; ARTICLE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; DISEASE TRANSMISSION; GENETIC POLYMORPHISM; HUMAN; IMMUNOGENICITY; MAJOR CLINICAL STUDY; MALARIA; MORBIDITY; NUCLEOTIDE SEQUENCE; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; SEASONAL VARIATION; SUDAN;

ADOLESCENT; ADULT; ANIMALS; ANTIBODIES, PROTOZOAN; ANTIBODY SPECIFICITY; ANTIGENIC VARIATION; CONSERVED SEQUENCE; FEMALE; GENOTYPE; HUMANS; LONGITUDINAL STUDIES; MALARIA, FALCIPARUM; MALE; MEROZOITE SURFACE PROTEIN 1; MOLECULAR SEQUENCE DATA; PLASMODIUM FALCIPARUM; POLYMORPHISM, GENETIC; PROTEIN PRECURSORS; PROTOZOAN PROTEINS; SUDAN;

EID: 7144229377     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (57)

1. Howard, R. J., and B. L. Pasloske. 1993. Target antigens for asexual malaria vaccine development. Parasitol. Today 9:369.
2. McBride, J. S., and H-G. Heidrich. 1987. Fragments of the polymorphic Mr 185,000 glycoprotein from the surface of isolated Plasmodium falciparum merozoites form an antigenic complex. Mol. Biochem. Parasitol. 23:71.
3. Holder, A. A., J. S. Sandhu, Y. Hillman, L. S. Davey, S. C. Nicholls, Cooper, H., and M. J. Lockyer. 1987. Processing of the precursor to the major merozoite surface antigens of Plasmodium falciparum. Parasitology 94:199.
4. Lyon, J. A., R. H. Geller, D. Haynes, J. D. Chulay, and J. L. Weir. 1986. Epitope map and processing scheme for the 195,000-dalton surface glycoprotein of Plasmodium falciparum merozoites deduced from cloned overlapping segments of the gene. Proc. Natl. Acad. Sci. USA 83:2989.
5. Blackman, M. J., H-G. Heidrich, S. Donachie, J. S. McBride, and A. A. Holder. 1990. A single fragment of a malaria merozoite surface protein remains on the parasite during red cell invasion and is the target of invasion-inhibiting antibodies. J. Exp. Med. 172:379.
6. 33 as a noncovalently associated complex with other fragments of MSP-1. Mol. Biochem. Parasitol. 50:307.
7. Siddiqui, W. A., L. Q. Tam, K. J. Kramer, G. S. Hui, K. M. Yamaga, S. P. Chang, E. B. Chan, and S. C. Kan. 1987. Merozoite surface coat precursor protein completely protects Aotus monkeys against Plasmodium falciparum malaria. Proc. Natl. Acad. Sci. USA 84:3014.
8. Hall R., J. E. Hyde, M. Goman, D. L. Simmons, I. A. Hope, M. Mackay, B. Merkli, R. Richle, and J. Stocker. 1984. Major surface antigen of a human malaria parasite cloned and expressed in bacteria. Nature 311:379.
9. Etlinger, H. M., P. Caspers, H. Matile, H-J. Schoenfield, D. Stueber, and B. Takacs. 1991. Ability of recombinant or native proteins to protect monkeys against heterologous challenge with Plasmodium falciparum. Infect. Immun. 59:3498.
10. Holder, A. A., R. R. Freeman, and S. C. Nicholls. 1988. Immunisation against Plasmodium falciparum with recombinant polypeptides produced in Escherichia coli. Parasite Immunol. 10:607.
11. Herrera, S., P. Caspers, D. Rotmann, F. Sinigaglia, and U. Certa. 1992. Protection against malaria in Aotus monkeys immunised with a recombinant blood stage antigen fused to a universal T-cell epitope: correlation of serum gamma interferon levels with protection. Infect. Immun. 60:154.
12. Kumar, S., A. Yadava, D. B. Keister, J. H. Tian, M. Ohl, K. A. Perdue-Greenfield, L. H. Miller, and D. C. Kaslow. 1995. Immunogenicity and in vivo efficacy of recombinant Plasmodium falciparum merozoite surface protein-1 in Aotus monkeys. Mol. Med. 1:325.
13. Chang, S. P., S. E. Case, W. L. Gosnell, A. Hashimoto, K. J. Kramer, L. Q. Tam, C. Q. Hashiro, C. M. Nikaido, H. L. Gibson, C. T. Lee-Ng, P. J. Barr, B. T. Yokota, and G. S. Hui. 1996. A recombinant baculovirus 42-kilodalton C-terminal fragment of Plasmodium falciparum merozoite protein 1 protects Aotus monkeys against malaria. Infect. Immun. 64:253.
14. Locher, C. P., L. Q. Tam, S. P. Chang, J. S. McBride, and W. A. Siddiqui. 1996. Plasmodium falciparum: gp195 tripeptide repeat-specific monoclonal antibody inhibits parasite growth in vitro. Exp. Parasitol 84:74.
15. Hui, G. S. N., A. Hashimoto, and S. P. Chang. 1992. Roles of conserved and allelic regions of the major merozoite surface protein (gp195) in immunity against Plasmodium falciparum. Infect. Immun. 60:1422.
16. Hui, G. S. N., W. L. Gosnell, S. E. Case, C. Hashiro, C. Nikaido, A. Hashimoto, and D. C. Kaslow. 1994. Immunogenicity of the C-terminal 19-kDa fragment of the Plasmodium falciparum: merozoite surface protein 1 (MSP1), YMSP119 expressed in S. cerevisiae. J. Immunol. 153:2544.
17. Tanabe, K., M. MacKay, M. Goman, and J. G. Scaife. 1987. Allelic dimorphism in a surface antigen of the malaria parasite Plasmodium falciparum. J. Mol. Biol. 195:273.
18. Miller, L. H., T. Roberts, M. Shahabuddin, and T. F. McCutchan. 1993. Analysis of sequence diversity in the Plasmodium falciparum merozoite protein-1 (MSP-1). Mol. Biochem. Parasitol. 59:1.
19. Chang, S. P., K. J. Kramer, K. M. Yamaga, A. Kato, S. E. Case, and W. A. Siddiqui. 1988. Plasmodium falciparum: gene structure and hydropathy profile of the major merozoite surface antigen (gp195) of the Uganda-Palo Alto isolate. Exp. Parasitol. 67:1.
20. Holder, A. A., M. J. Lockyer, K. G. Odink, J. S. Sandhu, V. Riveros-Moreno, S. C. Nicholls, Y. Hillman, L. S. Davey, M. L. V. Tizard, R. T. Schwarz, and R. R. Freeman. 1985. Primary structure of the precursor to the three major surface antigens of Plasmodium falciparum merozoites. Nature 317:270.
21. Certa, U., D. Rotmann, H. Matile, and R. Reber-Liske. 1987. A naturally occurring gene encoding the major surface antigen precursor P190 of Plasmodium falciparum lacks tripeptide repeats. EMBO J. 6:4137.
22. Holder, A. A., and E. M. Riley. 1996. Human immune response to MSP-1. Parasitol. Today 12:173.
23. 19, the carboxy-terminal fragment of the major merozoite surface protein of P. falciparum. Infect. Immun. 63:456.
24. Udhayakumar, V., D. Anyona, S. Kariuki, Y. P. Shi, P. B. Bloland, O. H. Branch, W. Weiss, B. L. Nahlen, D. C. Kaslow, and A. A. Lal. 1995. Identification of T and B cell epitopes recognized by humans in the C- terminal 42-kDa domain of the Plasmodium falciparum merozoite surface protein (MSP)-1. J. Immunol. 154:6022.
25. Shi, Y. P., U. Sayed, S. H. Qari, J. M. Roberts, V. Udhayakumar, A. J. Oloo, W. A. Hawley, D. C. Kaslow, B. L. Nahlen, and A. A. Lal. 1996. Natural immune response to the C-terminal 19-kilodalton domain of Plasmodium falciparum merozoite surface protein-1. Infect. Immun. 64:2716.
26. Riley, E. M., S. J. Allen, J. G. Wheeler, M. J. Blackman, S. Bennett, B. Takacs, H. J. Schonfeld, A. A. Holder, and B. M. Greenwood. 1992. Naturally acquired cellular and humoral immune responses to the major merozoite surface antigen (PfMSP1) of Plasmodium falciparum are associated with reduced malaria morbidity. Parasite Immunol. 14:321.
27. Al-Yaman, F., B. Genton, K. J. Kramer, S. P. Chang, G. S. Hui, M. Baisor, and M. P. Alpers. 1996. Assessment of the role of naturally acquired antibody levels to Plasmodium falciparum merozoite surface protein-1 in protecting Papua New Guinea children from malaria morbidity. Am. J. Trop. Med. Hyg. 54:443.
28. Patarroyo, M. E., R. Amador, P. Clavijo, A. Moreno, F. Guzman, P. Romero, R. Tascon, A. Franco, L. A. Murillo, G. Ponton, and G. Trujillo. 1988. A synthetic vaccine protects humans against challenge with asexual blood stages of Plasmodium falciparum malaria. Nature 332:158.
29. Alessandro, U. D., A. Leach, C. J. Drakeley, S. Bennett, B. O. Olaleye, G. W. Fegan, M. Jawara, P. Langerock, M. O. George, G. A. T. Targett, and B. M. Greenwood. 1995. Efficacy trial of malaria vaccine SPf66 in Gambian children. Lancet 346:462.
30. Alonso, P. L., T. Smith, J. R. M. A. Schellenberg, H. Masanja, S. Mwankusye, H. Urassa, I. B. Deazevedo, J. Chongela, S. Kobero, C. Menendez, N. Hurt, M. C. Thomas, E. Lyimo, N. A. Weiss, R. Hayes, A. Y. Kitua, M. C. Lopez, W. L. Kilama, T. Teuscher, and M. Tanner. 1994. Randomized trial of efficacy of spf66 vaccine against Plasmodium falciparum malaria in children in southern Tanzania. Lancet 344:1175.
31. Müller, H-M., K. Früh, A. von Brunn, F. Esposito, S. Lombardi, A. Crisanti, and H. Bujard. 1989. Development of the human immune response against the major surface protein (gp190) of Plasmodium falciparum. Infect. Immun. 57:3765.
32. Früh, K., O. Doumbo, H-M. Müller, O. Koita, J. S. McBride, A. Crisanti, Y. Touré, and H. Bujard. 1991. Human antibody response to the major merozoite surface antigen of Plasmodium falciparum is strain specific and short lived. Infect. Immun. 59:1319.
33. Chizzolini, C., A. Dupont, J. P. Akue, M. H. Kaufman, A. S. Verdini, A. Pessi, and G. Del Giudice. 1988. Natural antibodies against three distinct and defined antigens of Plasmodium falciparum in residents of a mesoendemic area in Gabon. Am. J. Trop. Med. Hyg. 39:150.
34. Tolle, R., K. Früh, O. Doumbo, O. Koita, M. N'Diaye, A. Fischer, K. Dietz, and H. Bujard. 1993. A prospective study of the association between human humoral immune response to Plasmodium falciparum blood stage antigen gp190 and control of malaria infections. Infect. Immun. 61:40.
35. Hughes, A. L. 1992. Positive selection and interallelic recombination at the merozoite surface antigen-1 (MSA-1) locus of Plasmodium falciparum. Mol. Biol. Evol. 9:381.
36. Theander, T. G., L. Hviid, Y. A. Abu-Zeid, N. H. Abdulhadi, B. O. Saeed, P. H. Jakobsen, C. M. Reimert, S. Jepsen, R. A. L. Bayoumi, and J. B. Jensen. 1990. Reduced cellular immune reactivity in healthy individuals during the malaria transmission season. Immunol. Lett. 25:237.
37. Elhassan, I. M., L. Hviid, P. H. Jakobsen, H. Giha, G. M. H. Satti, D. E. Arnot, J. B. Jensen, and T. G. Theander. 1995. High proportion of subclinical Plasmodium falciparum infections in an area of seasonal and unstable malaria in Sudan. Am. J. Trop. Med. Hyg. 53:78.
38. Roper, C., I. M. Elhassan, L. Hviid, H. Giha, W. Richardson, H. Babiker, G. M. H. Satti, T. G. Theander, and D. E. Amot. 1996. Detection of very low level P. falciparum infections using the nested polymerase chain reaction and a reassessment of the epidemiology of unstable malaria in Sudan. Am. J. Trop. Med. Hyg. 54:325.
39. Fenton, B., J. T. Clark, C. M. A. Khan, V. J. Robinson, D. Walliker, R. Ridley, J. G. Scaife, and J. S. McBride. 1991. Structure and antigenic polymorphism of the 35- to 48-kilodalton merozoite surface antigen (MSA-2) of the malaria parasite Plasmodium falciparum. Mol. Cell. Biol. 11:963.
40. Smith, D. B., and K. S. Johnson. 1988. Single step purification of polypeptides expressed in E. coli as fusions with glutathione S-transferase. Gene 67:31.
41. Cavanagh, D. R., and J. S. McBride. 1997. Antigenicity of recombinant proteins derived from Plasmodium falciparum merozoite surface protein 1. Mol. Biochem. Parasitol. 85:197.
42. Burghaus, P. A., and A. A. Holder. 1994. Expression of the 19kDa carboxyterminal fragment of Plasmodium falciparum merozoite surface protein-1 in Escherichia coli as a correctly folded protein. Mol. Biochem. Parasitol. 64:165.
43. Modiano, D., V. Petrarca, B. S. Sirima, I. Nebie, D. Diallo, F. Esposito, and M. Coluzzi. 1996. Different response to Plasmodium falciparum malaria in West African sympatric ethnic groups. Proc. Natl. Acad. Sci. USA 93:1326.
44. Good, M. F., J. A. Berzofsky, and W. L. Maloy. 1986. Genetic control of the immune response in mice to a Plasmodium falciparum sporozoite vaccine: widespread nonresponsiveness to single malaria T epitope in highly repetitive vaccine. J. Exp. Med. 164:655.
45. Del Guidice, G., J. A. Cooper, J. Merino, A. S. Verdini, A. Pessi, A. R. Togna, H. D. Engers, G. Corradin, and P. H. Lambert. 1986. The antibody response in mice to carrier-free synthetic polymers of Plasmodium falciparum circumsporozoite repetitive epitope is I-Ab-restricted: possible implications for malaria vaccines. J. Immunol. 137:2952.
46. Nardin, E. H., P. J. Barr, E. Heimer, and H. M. Etlinger. 1988. Genetic restriction of the murine humoral response to a recombinant Plasmodium vivax circumsporozoite protein. Eur. J. Immunol. 18:1119.
47. Chang, S. P., G. S. N. Hui, A. Kato, and W. A. Siddiqui. 1989. Generalized immunological recognition of the major merozoite surface antigen (gp195) of Plasmodium falciparum. Proc. Natl. Acad. Sci. USA 86:6343.
48. Graves, P. M., K. Bhatia, T. R. Burkot, M. Prasad, R. A. Wirtz, and P. Beckers. 1989. Association between HLA type and antibody response to malaria sporozoite and gamete epitopes is not evident in immune Papua New Guineans. Clin. Exp. Immunol. 78:418.
49. Riley, E. M., C. S. L. Ong, O. Olerup, S. Eida, S. J. Allen, S. Bennett, G. Andersson, and G. A. T. Targett. 1990. Cellular and humoral immune-responses to Plasmodium falciparum gametocyte antigens in malaria-immune individuals: limited response to the 48/45-kilodalton surface-antigen does not appear to be due to MHC restriction. J. Immunol. 144:4810.
50. Troye-Blomberg, M., O. Olerup, Å. Larsson, K. Sjöberg, H. Perlmann, E. Riley, J.-P. Lepers, and P. Perlmann. 1991, Failure to detect MHC class II associations of the human immune response induced by repeated malaria infections to the P. falciparum antigen Pf155/RESA. Int. Immunol. 3:1043.
51. Riley, E. M., O. Olerup, S. Bennett, P. Rowe, S. J. Allen, M. J. Blackman, M. Troye-Blomberg, A. A. Holder, and B. M. Greenwood. 1992. MHC and malaria: the relationship between HLA class II alleles and immune responses to Plasmodium falciparum. Int. Immunol. 4:1055.
52. Riley, E. M., S. Bennett, A. Jepson, M. Hassan-King, H. C. Whittle, O. Olerup, and R. Carter. 1994. Human antibody responses to Pfs 230, a sexual stage-specific surface antigen of Plasmodium falciparum: non-responsiveness is a stable phenotype but does not appear to be genetically regulated. Parasite Immunol. 16:55.
53. Riley, E. M. 1996. The role of MHC- and non-MHC associated genes in determining the human immune response to malaria antigens. Parasitology 112:S39.
54. Taylor, R. R., A. Egan, D. McGuiness, A. Jepson, R. Adair, C. Drakely, and E. M. Riley. 1996. Selective recognition of malaria antigens by human serum antibodies is not genetically determined but is reminiscent of clonal imprinting. Int. Immunol. 8:905.
55. Anders, R. F. 1986. Multiple cross-reactivities amongst antigens of Plasmodium falciparum impair the development of protective immunity against malaria. Parasite Immunol. 8:529.
56. Schofield, L. 1991. On the function of repetitive domains in protein antigens of Plasmodium and other eukaryotic parasites. Parasitol. Today 7:99.
57. Roper, C., W. Richardson, I.M. Elhassan, H. Giha, L. Hviid, G.M.H. Satti, T.G. Theander and D.E. Arnot. 1998. Seasonal changes in the Plasmodium falciparum population in individuals and their relationship to clinical malaria: a longitudinal study in a Sudanese village. Parasitology 116, in press.